Drug Shortage Report for NABUMETONE
| Report ID | 119621 |
| Drug Identification Number | 02238639 |
| Brand name | NABUMETONE |
| Common or Proper name | Nabumetone |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NABUMETONE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BTL |
| ATC code | M01AX |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-07 |
| Estimated end date | 2020-09-04 |
| Actual end date | 2020-09-02 |
| Shortage status | Resolved |
| Updated date | 2020-09-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-07-07 | English | Compare |
| v2 | 2020-07-07 | French | Compare |
| v3 | 2020-07-08 | English | Compare |
| v4 | 2020-07-23 | English | Compare |
| v5 | 2020-07-23 | French | Compare |
| v6 | 2020-08-18 | English | Compare |
| v7 | 2020-08-18 | French | Compare |
| v8 | 2020-09-02 | English | Compare |
| v9 | 2020-09-02 | French | Compare |
| v10 | 2020-09-03 | English | Compare |
Showing 1 to 10 of 10